You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 8, August 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Childhood Adrenoleukodystrophy

Failure of Intensive Immunosuppression to Arrest Neurologic Progression

Sakkubai Naidu, MB, BS; Michael J. Bresnan, MD; Diane Griffin, MD; Susan O'Toole, RN, MS; Hugo W. Moser, MD

Arch Neurol. 1988;45(8):846-848.


Abstract

• Cyclophosphamide in a dosage of 350 to 700 mg/m2/d was administered for five to 11 days to four patients with childhood adrenoleukodystrophy (ALD) and to one patient with the adult cerebral form of the disease. The rate of neurologic progression in the four patients with childhood ALD did not differ from that of 167 untreated patients with childhood ALD surveyed previously.



Author Affiliations

From the John F. Kennedy Institute (Drs Naidu and Moser and Ms O'Toole) and Departments of Neurology and Pediatrics (Drs Naidu, Griffin, and Moser), The Johns Hopkins University, Baltimore; and the Department of Neurology, Harvard University and the Children's Medical Center (Dr Bresnan), Boston.


Footnotes

Accepted for publication Feb 22, 1988.

Deceased.

Reprint requests to John F. Kennedy Institute, 707 N Broadway, Baltimore, MD 21205 (Dr Naidu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis
Spurek et al.
CMAJ 2004;171:1073-1077.
ABSTRACT | FULL TEXT  

Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"
van Geel et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:290-299.
ABSTRACT | FULL TEXT  

A mouse model for X-linked adrenoleukodystrophy
Lu et al.
Proc. Natl. Acad. Sci. USA 1997;94:9366-9371.
ABSTRACT | FULL TEXT  

X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy
van Geel et al.
J. Neurol. Neurosurg. Psychiatry 1997;63:4-14.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.